Role of leukotriene B4 receptors in the interplay of inflammation and infection

白三烯 B4 受体在炎症和感染相互作用中的作用

基本信息

  • 批准号:
    8210894
  • 负责人:
  • 金额:
    $ 29.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-01 至 2014-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Colon cancer is a leading cause of cancer related deaths in the United States. Exposure to a number of hazardous environmental agents and consumption of the Western diet are known to contribute to the pathogenesis of malignant colon cancer. While chronic inflammation is known to be a major promoter of tumor development the role of gut microflora in contributing to the colon cancer is unknown. Our laboratory has identified leukotriene B4 receptor, BLT1 as a major regulator of inflammation and host response to infections. In a mouse model of spontaneous intestinal cancer (ApcMin/+), we have made the observation that absence of BLT1 greatly enhances intestinal tumor development. This has led to the central hypothesis that Absence of BLT1 enhances colon tumor development by defective immune surveillance and/or altered microbial gut homeostasis. This apparently paradoxical result that loss of a proinflammatory mediator increases inflammation and tumor development suggests that the ever changing micro environment of intestine can have a major influence on the development of colorectal cancer. The current proposal will test this hypothesis in three specific aims. In aim 1, we will examine the mechanisms of leukotriene B4 pathway mediated protection of intestinal cancers in ApcMin/+ mice. Aim 2 will establish the immune functions in tumor bearing mice in the context of BLT1+/+ and BLT1-/- mice. Aim 3 will test the novel concept that defective host response and altered gut microbiota are responsible for rapid development of colon tumors in BLT1-/- mice. These studies will provide a comprehensive model system to examine the interplay of inflammation and infections to the development of colon cancer. Since the mouse ApcMin/+ model is highly related to human colon cancers the result will have direct and immediate impact for the treatment of human colon cancer. PUBLIC HEALTH RELEVANCE: Leukotrienes are involved in the pathophysiology of many acute and chronic inflammatory diseases such as systemic anaphylaxis, asthma, atherosclerosis and arthritis. The novel finding that leukotriene B4-leukotriene B4 receptor1 axis may have a protective function in the development of colon cancer offers a unique opportunity to understand the role of these mediators in tumor development. Understanding the precise function of distinct leukotriene B4 receptors in mice and defining the role of these receptors in host defense and shaping the gut microflora will provide novel approaches to the treatment of colon cancer.
描述(申请人提供):结肠癌是美国癌症相关死亡的主要原因。众所周知,接触一些有害的环境物质和食用西方饮食是导致恶性结肠癌的原因之一。虽然慢性炎症已知是肿瘤发展的主要促进因素,但肠道菌群在结肠癌中的作用尚不清楚。我们的实验室已经确定白三烯B4受体BLT1是炎症和宿主对感染反应的主要调节因子。在自发性肠癌的小鼠模型(ApcMin/+)中,我们观察到BLT1的缺失极大地促进了肠道肿瘤的发展。这导致了一个中心假说,即BLT1的缺失通过缺陷的免疫监视和/或改变微生物肠道稳态来促进结肠癌的发展。这一明显自相矛盾的结果表明,肠道微环境的不断变化可能对结直肠癌的发展产生重大影响。目前的提案将在三个具体目标上检验这一假设。目的1,探讨白三烯B4途径对ApcMin/+小鼠肠癌的保护作用机制。目的2以BLT1+/+和BLT1-/-小鼠为研究对象,建立荷瘤小鼠的免疫功能。目的3将测试这一新概念,即宿主反应缺陷和肠道微生物区系改变是导致BLT1-/-小鼠结肠癌快速发展的原因。这些研究将提供一个全面的模型系统,以检验炎症和感染对结肠癌发展的相互作用。由于小鼠ApcMin/+模型与人类结肠癌高度相关,这一结果将对人类结肠癌的治疗产生直接和即时的影响。公共卫生相关性:白三烯参与许多急慢性炎症性疾病的病理生理学,如全身过敏反应、哮喘、动脉粥样硬化和关节炎。白三烯B4-白三烯B4受体1轴可能在结肠癌的发生发展中起保护作用,这一新发现为理解这些介质在肿瘤发生中的作用提供了一个独特的机会。了解小鼠体内不同的白三烯B4受体的确切功能,并确定这些受体在宿主防御和塑造肠道微生物区系中的作用,将为结肠癌的治疗提供新的方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HARIBABU BODDULURI其他文献

HARIBABU BODDULURI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HARIBABU BODDULURI', 18)}}的其他基金

Functional Microbiomics Core-Bodduluri
功能微生物组学核心-Bodduluri
  • 批准号:
    10349568
  • 财政年份:
    2018
  • 资助金额:
    $ 29.66万
  • 项目类别:
Functional Microbiomics Core
功能微生物组学核心
  • 批准号:
    10492098
  • 财政年份:
    2018
  • 资助金额:
    $ 29.66万
  • 项目类别:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
白三烯 B4 受体在炎症和感染相互作用中的作用
  • 批准号:
    8433515
  • 财政年份:
    2009
  • 资助金额:
    $ 29.66万
  • 项目类别:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
白三烯 B4 受体在炎症和感染相互作用中的作用
  • 批准号:
    8015283
  • 财政年份:
    2009
  • 资助金额:
    $ 29.66万
  • 项目类别:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
白三烯 B4 受体在炎症和感染相互作用中的作用
  • 批准号:
    7635082
  • 财政年份:
    2009
  • 资助金额:
    $ 29.66万
  • 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
  • 批准号:
    7032234
  • 财政年份:
    2003
  • 资助金额:
    $ 29.66万
  • 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
  • 批准号:
    6706978
  • 财政年份:
    2003
  • 资助金额:
    $ 29.66万
  • 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
  • 批准号:
    6610703
  • 财政年份:
    2003
  • 资助金额:
    $ 29.66万
  • 项目类别:
Leukotriene B4 Receptors in Rheumatoid Arthritis
类风湿关节炎中的白三烯 B4 受体
  • 批准号:
    6858582
  • 财政年份:
    2003
  • 资助金额:
    $ 29.66万
  • 项目类别:
REGULATION OF HIV-1 CORECEPTORS
HIV-1 辅助受体的调节
  • 批准号:
    6019921
  • 财政年份:
    2000
  • 资助金额:
    $ 29.66万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.66万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 29.66万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.66万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.66万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.66万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.66万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.66万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 29.66万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 29.66万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 29.66万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了